Depletion of atrial natriuretic peptide during longstanding atrial fibrillation

Europace

Volumn 6, Issue 5, 2004, Pages 433-437

  van den Berg, Maarten P ^a   van Gelder, Isabelle C ^a   van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atrial fibrillation; Atrial natriuretic peptide; Cardioversion; Depletion; Heart failure; Maze procedure

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; COLLAGEN;

CARDIOVERSION; CHRONIC DISEASE; CORRELATION ANALYSIS; EXERCISE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HUMAN; NATRIURESIS; NONHUMAN; PATIENT SELECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DEPLETION; RETROSPECTIVE STUDY; REVIEW; SINUS RHYTHM; TREATMENT OUTCOME; VASODILATATION;

ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; HUMANS; MYOCYTES, CARDIAC; TIME FACTORS;

EID: 4344668160     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2004.04.006     Document Type: Review

References (30)

1. de Bold A.J. Borenstein H.B. Veress A.T. Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats Life Sci 28 1981 89-94
2. Levin E.R. Gardner D.G. Samson W.K. Natriuretic peptides N Engl J Med 339 1998 321-328
3. Kalra P.R. Tigas S. Regulation of lipolysis: natriuretic peptides and the development of cachexia Int J Cardiol 85 2002 125-132
4. Jansen W.M.T. de Zeeuw D. van der Hem G.K. de Jong P.E. Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans Hypertension 13 1989 640-646
5. Packer M. Califf R.M. Konstam M.A. et al. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) Circulation 106 2002 920-926
6. Nagate M. Hiroe M. Naruse M. et al. An integrated study employing histopathological, immunohistocytochemical and radioimmunoassay analyses of atrial natriuretic peptide in the right and left atria in patients with mitral valve disease Jpn Circ J 52 1988 1453-1456
7. Saito Y. Nakao K. Sugawara A. et al. Atrial natriuretic polypeptide during exercise in healthy man Acta Endocrinol 116 1987 59-65
8. Vardas P.E. Travill C.M. Williams T.D.M. Ingram A.M. Lightman S.L. Sutton R. Effect of dual chamber pacing on raised plasma atrial natriuretic peptide concentrations in complete atrioventricular block Br Med J 296 1988 94
9. Francis G.S. Benedict C. Johnstone D.E. et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction Circulation 82 1990 1724-1729
10. Throughton R.W. Frampton C.M. Yandle T.G. Espiner E.A. Nicholls M.G. Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126-1130
11. Gottlieb S.S. Kukin M.L. Ahern D. Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure J Am Coll Cardiol 13 1989 1534-1539
12. Schiebinger R.J. Linden J. Effect of atrial contraction frequency on atrial natriuretic peptide secretion Am J Physiol 251 1986 H1095-H1099
13. Walsh K.P. Williams T.D.M. Spiteri C. Pitts E. Lightman S.L. Sutton R. Role of atrial pressure and rate in release of atrial natriuretic peptide Am J Physiol 254 1988 R607-R610
14. Vardas P.E. Walsh K.P. Travill C.M. et al. Relation of atrial natriuretic peptide release to atrial contraction Am J Cardiol 63 1989 753-755
15. Schoonderwoerd BA, Crijns HJGM, van Veldhuisen DJ, et al. Atrial natriuretic peptides during experimental atrial tachycardia. Role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol, in press.
16. Roy D. Paillard F. Cassidy D. et al. Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia J Am Coll Cardiol 9 1987 509-514
17. Arakawa M. Miwa H. Kambara K. et al. Changes in plasma concentrations of atrial natriuretic peptides after cardioversion of chronic atrial fibrillation Am J Cardiol 70 1992 550-552
18. Ausma J. Wijffels M. Thoné F. Wouters L. Allessie M. Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 1997 3157-3163
19. Davies M.J. Pomerance A. Pathology of atrial fibrillation in man Br Heart J 34 1972 520-525
20. Aimé-Sempé C. Folliguet T. Rücker-Martin C. et al. Myocardial cell in death in fibrillating and dilated human right atria J Am Coll Cardiol 34 1999 1577-1586
21. Seino Y. Shimai S. Ibuki C. Itoh K. Takano T. Hayakawa H. Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence J Am Coll Cardiol 18 1991 459-463
22. van den Berg M.P. Crijns H.J.G.M. van Veldhuisen D.J. van Gelder I.C. de Kam P.J. Lie K.I. Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation. Role of duration of atrial fibrillation Am Heart J 5 1998 242-244
23. van den Berg M.P. Tjeerdsma G. de Kam P.J. Boomsma F. Crijns H.J.G.M. van Veldhuisen D.J. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure Eur J Heart Fail 4 2002 255-262
24. Theodorakis G.N. Markianos M. Kouroubetsis C.K. Livanis E.G. Paraskevaidis I.A. Kremastinos D.T. Clinical, adrenergic and heart endocrine measures in chronic atrial fibrillation as predictors of conversion and maintenance of sinus rhythm after direct current cardioversion Eur Heart J 17 1996 550-556
25. Wozakowska-Kaplon B. Opolski G. Kosior D. Janion M. An increase in plasma atrial natriuretic peptide concentration during exercise predicts a successful cardioversion and maintenance of sinus rhythm in patients with chronic atrial fibrillation Pacing Clin Electrophysiol 23 2000 1876-1879
26. Yoshihara F. Nishikimi T. Sasako Y. et al. Plasma atrial natriuretic peptide concentration correlates conversely with left atrial collagen volume fraction in patients with atrial fibrillation. Plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure J Am Coll Cardiol 39 2002 288-294
27. Doyama K. Fukumoto M. Takemura G. et al. Expression and distribution of brain natriuretic peptide in human right atria J Am Coll Cardiol 32 1998 1832-1838
28. Dries D.L. Exner D.V. Gersh B.J. Domanski M.J. Waclawiw M.A. Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695-703
29. Wyse D.G. Waldo A.L. Dimarco J.P. et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825-1833
30. Van Gelder I.C. Hagens V.E. Bosker H.A. et al. for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834-1840